Epoprostenol FDA Link Generic

A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).

Also Known As:

Prostacyclin; Epoprostenol Sodium; Flolan; Epoprostanol; Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer; Prostaglandin I(2); Veletri; Prostaglandin I2; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-

Pharmalogical Action Categories:

Antihypertensive Agents
Platelet Aggregation Inhibitors

Lipids: 118169
- Fatty Acids: 28212
  - Unsaturated Fatty Acids: 8458
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Prostaglandins I: 109
        Epoprostenol: 4695
Biological Factors: 2560
- Inflammation Mediators: 1126
  - Autacoids: 278
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Prostaglandins I: 109
        Epoprostenol: 4695

M Galfi Selected Research

M Galfi Research Topics

Disease

Drug/Important Bio-Agent (IBA)